- Current report filing (8-K)
16 7월 2009 - 10:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported):
July 16,
2009
KBL HEALTHCARE ACQUISITION
CORP. III
(Exact
Name of Registrant as Specified in Charter)
Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
001-33583
(Commission
File
Number)
|
20-8191477
(IRS
Employer
Identification
No.)
|
380 Lexington Avenue,
31st Floor, New York, New York
|
10168
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
212-319-5555
(Registrant’s
Telephone Number, Including Area Code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
x
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e 4(c))
|
On July
16, 2009, KBL Healthcare Acquisition Corp. III (“KBL”) and PRWT Services, Inc.
(“PRWT”) announced the joint termination of the Agreement and Plan of
Reorganization, dated as of March 13, 2009, as amended by and among KBL,
PRWT, the stockholders of PRWT and PRWT Merger Sub,, a wholly-owned subsidiary
of PRWT.
As a
result of the foregoing, pursuant to KBL’s amended and restated certificate of
incorporation, KBL’s corporate existence will cease, effective July 19, 2009,
except for the purposes of winding up its affairs and
liquidating. Under the Delaware General Corporation Law, KBL is now
required to pay or make reasonable provision for all existing claims and
obligations, including all contingent, conditional, or unmatured contractual
claims known to KBL, and to provide compensation for any claims that have not
been made known to KBL or that have not arisen but that, based on facts known to
KBL at this time, are likely to arise or to become known to KBL within 10 years
after such date. KBL cannot make any assurance as to when such plan will be
completed and when liquidation distributions will be made, although KBL intends
to complete such process as soon as practicable.
A copy of
the press release announcing the termination is attached to this Report as
Exhibit 99.1.
Item
9.01.
|
Financial
Statement and Exhibits.
|
|
99.1
|
Press
Release, dated July 16, 2009.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
July 16, 2009
|
|
|
|
|
|
|
KBL
HEALTHCARE ACQUISITION CORP. III
|
|
|
|
|
|
|
By:
|
/s/
Michael
Kaswan
|
|
|
|
Michael
Kaswan
|
|
|
|
Chief
Operating Officer
|
|
EXHIBIT
INDEX
|
99.1
|
Press
Release, dated July 16, 2009.
|
Kbl Healthcare Acquisition Iii (AMEX:KHA)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Kbl Healthcare Acquisition Iii (AMEX:KHA)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024